Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Nagarajah, J."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 27
Tytuł:
Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT.
Autorzy:
Grob D; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Healthcare and Information Technology, Slingeland Hospital, Doetinchem, The Netherlands.
Privé BM; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Radiation Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.
Muselaers CHJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Nagarajah J; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Konijnenberg MW; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Peters SMB; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. .
Pokaż więcej
Źródło:
EJNMMI physics [EJNMMI Phys] 2024 Apr 03; Vol. 11 (1), pp. 34. Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of Lu-PSMA-617 in prostate cancer patients.
Autorzy:
Siebinga H; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Privé BM; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Peters SMB; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Nagarajah J; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Dorlo TPC; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
de Wit-van der Veen BJ; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Hendrikx JJMA; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Aug; Vol. 12 (8), pp. 1060-1071. Date of Electronic Publication: 2023 Feb 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Radiopharmaceuticals*/pharmacokinetics
Radiopharmaceuticals*/therapeutic use
Prostatic Neoplasms, Castration-Resistant*/drug therapy
Male ; Humans ; Dipeptides ; Prostate-Specific Antigen
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies.
Autorzy:
Privé BM; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands. .; Department of Radiation Oncology, Erasmus MC, Rotterdam, The Netherlands. .
Boussihmad MA; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.
Timmermans B; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.
van Gemert WA; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.
Peters SMB; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.
Derks YHW; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.
van Lith SAM; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.
Mehra N; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.
Nagarajah J; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.
Heskamp S; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.
Westdorp H; Department of Radiology and Nuclear Medicine, PO Box 9101, Radboudumc, 6500 HB, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jun; Vol. 50 (7), pp. 1906-1918. Date of Electronic Publication: 2023 Feb 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Membrane Proteins*/metabolism
Radioisotopes*/therapeutic use
Humans ; Cell Line, Tumor ; Protein Transport ; Fibroblasts/metabolism ; Positron Emission Tomography Computed Tomography ; Gallium Radioisotopes
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Head-To-Head Comparison of PET and Perfusion Weighted MRI Techniques to Distinguish Treatment Related Abnormalities from Tumor Progression in Glioma.
Autorzy:
Henssen D; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Radboudumc Center of Expertise Neuro-Oncology, 6525 GA Nijmegen, The Netherlands.
Leijten L; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Meijer FJA; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Radboudumc Center of Expertise Neuro-Oncology, 6525 GA Nijmegen, The Netherlands.
van der Kolk A; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Radboudumc Center of Expertise Neuro-Oncology, 6525 GA Nijmegen, The Netherlands.; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Arens AIJ; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Ter Laan M; Radboudumc Center of Expertise Neuro-Oncology, 6525 GA Nijmegen, The Netherlands.; Department of Neurosurgery, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Smeenk RJ; Radboudumc Center of Expertise Neuro-Oncology, 6525 GA Nijmegen, The Netherlands.; Department of Radiation Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Gijtenbeek A; Radboudumc Center of Expertise Neuro-Oncology, 6525 GA Nijmegen, The Netherlands.; Department of Neurology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
van de Giessen EM; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, 1100 DD Amsterdam, The Netherlands.
Tolboom N; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, 1100 DD Amsterdam, The Netherlands.
Smits M; Department of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.; Brain Tumor Center, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.; Medical Delta, 2629 JH Delft, The Netherlands.
Nagarajah J; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 May 05; Vol. 15 (9). Date of Electronic Publication: 2023 May 05.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation.
Autorzy:
Peters SMB; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. .
Mink MCT; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Physics and Astronomy, Radboud University, Nijmegen, The Netherlands.
Privé BM; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
de Bakker M; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
de Lange F; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Muselaers CHJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Gotthardt M; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Nagarajah J; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Konijnenberg MW; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Pokaż więcej
Źródło:
EJNMMI research [EJNMMI Res] 2023 Jan 24; Vol. 13 (1), pp. 6. Date of Electronic Publication: 2023 Jan 24.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study.
Autorzy:
Banda A; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, P.O. Box 9101, 6525 GA Nijmegen, The Netherlands.
Privé BM; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, P.O. Box 9101, 6525 GA Nijmegen, The Netherlands.
Allach Y; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, P.O. Box 9101, 6525 GA Nijmegen, The Netherlands.
Uijen MJM; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, P.O. Box 9101, 6525 GA Nijmegen, The Netherlands.
Peters SMB; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, P.O. Box 9101, 6525 GA Nijmegen, The Netherlands.
Loeff CC; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, P.O. Box 9101, 6525 GA Nijmegen, The Netherlands.
Gotthardt M; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, P.O. Box 9101, 6525 GA Nijmegen, The Netherlands.
Muselaers CHJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, P.O. Box 9101, 6525 GA Nijmegen, The Netherlands.
Witjes JA; Department of Medical Oncology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
van Oort IM; Department of Medical Oncology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
Sedelaar JPM; Department of Medical Oncology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
Westdorp H; Department of Urology and Oncology, Radboud Universiteit Medical Center, 6525 GA Nijmegen, The Netherlands.
Mehra N; Department of Urology and Oncology, Radboud Universiteit Medical Center, 6525 GA Nijmegen, The Netherlands.
Khreish F; Department of Nuclear Medicine, University of Saarland, D-66421 Homburg, Germany.
Ezziddin S; Department of Nuclear Medicine, University of Saarland, D-66421 Homburg, Germany.
Sabet A; University Hospital, Department of Nuclear Medicine, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany.
Kreissl MC; Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, Magdeburg University Hospital, 39120 Magdeburg, Germany.
Winkens T; Clinic for Nuclear Medicine, University Hospital of Jena, 07743 Jena, Germany.
Seifert P; Clinic for Nuclear Medicine, University Hospital of Jena, 07743 Jena, Germany.
Janssen MJR; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, P.O. Box 9101, 6525 GA Nijmegen, The Netherlands.
van Gemert WAM; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, P.O. Box 9101, 6525 GA Nijmegen, The Netherlands.
Nagarajah J; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, P.O. Box 9101, 6525 GA Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Dec 31; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 31.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
[ Zr]Zr-PSMA-617 PET/CT in biochemical recurrence of prostate cancer: first clinical experience from a pilot study including biodistribution and dose estimates.
Autorzy:
Rosar F; Department of Nuclear Medicine, Saarland University - Medical Center, Kirrberger Str. 100, Geb. 50, 66421, Homburg, Germany.
Schaefer-Schuler A; Department of Nuclear Medicine, Saarland University - Medical Center, Kirrberger Str. 100, Geb. 50, 66421, Homburg, Germany.
Bartholomä M; Department of Nuclear Medicine, Saarland University - Medical Center, Kirrberger Str. 100, Geb. 50, 66421, Homburg, Germany.
Maus S; Department of Nuclear Medicine, Saarland University - Medical Center, Kirrberger Str. 100, Geb. 50, 66421, Homburg, Germany.
Petto S; Department of Nuclear Medicine, Saarland University - Medical Center, Kirrberger Str. 100, Geb. 50, 66421, Homburg, Germany.
Burgard C; Department of Nuclear Medicine, Saarland University - Medical Center, Kirrberger Str. 100, Geb. 50, 66421, Homburg, Germany.
Privé BM; Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Franssen GM; Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Derks YHW; Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Nagarajah J; Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Khreish F; Department of Nuclear Medicine, Saarland University - Medical Center, Kirrberger Str. 100, Geb. 50, 66421, Homburg, Germany.
Ezziddin S; Department of Nuclear Medicine, Saarland University - Medical Center, Kirrberger Str. 100, Geb. 50, 66421, Homburg, Germany. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Nov; Vol. 49 (13), pp. 4736-4747. Date of Electronic Publication: 2022 Aug 05.
Typ publikacji:
Journal Article
MeSH Terms:
Positron Emission Tomography Computed Tomography*/methods
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/pathology
Male ; Humans ; Gallium Radioisotopes ; Tissue Distribution ; Pilot Projects ; Radioisotopes
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tracked 3D ultrasound and deep neural network-based thyroid segmentation reduce interobserver variability in thyroid volumetry.
Autorzy:
Krönke M; Department of Radiology and Nuclear Medicine, German Heart Center, Technical University of Munich, Munich, Germany.; Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany.
Eilers C; Chair for Computer Aided Medical Procedures and Augmented Reality, Department of Computer Science, Technical University of Munich, Garching Near Munich, Germany.
Dimova D; Chair for Computer Aided Medical Procedures and Augmented Reality, Department of Computer Science, Technical University of Munich, Garching Near Munich, Germany.
Köhler M; Chair for Computer Aided Medical Procedures and Augmented Reality, Department of Computer Science, Technical University of Munich, Garching Near Munich, Germany.; Medical Faculty, Technical University of Munich, Munich, Germany.
Buschner G; Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany.
Schweiger L; Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany.
Konstantinidou L; Chair for Computer Aided Medical Procedures and Augmented Reality, Department of Computer Science, Technical University of Munich, Garching Near Munich, Germany.
Makowski M; Department of Radiology, School of Medicine, Technical University of Munich, Munich, Germany.
Nagarajah J; Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Navab N; Chair for Computer Aided Medical Procedures and Augmented Reality, Department of Computer Science, Technical University of Munich, Garching Near Munich, Germany.; Chair for Computer Aided Medical Procedures, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, United States of America.
Weber W; Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany.
Wendler T; Chair for Computer Aided Medical Procedures and Augmented Reality, Department of Computer Science, Technical University of Munich, Garching Near Munich, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Jul 29; Vol. 17 (7), pp. e0268550. Date of Electronic Publication: 2022 Jul 29 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neural Networks, Computer*
Thyroid Gland*/diagnostic imaging
Humans ; Image Processing, Computer-Assisted ; Magnetic Resonance Imaging ; Observer Variation ; Ultrasonography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Zr-labeled PSMA ligands for pharmacokinetic PET imaging and dosimetry of PSMA-617 and PSMA-I&T: a preclinical evaluation and first in man.
Autorzy:
Privé BM; Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. .
Derks YHW; Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Rosar F; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany.
Franssen GM; Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Peters SMB; Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Khreish F; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany.
Bartholomä M; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany.
Maus S; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany.
Gotthardt M; Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Laverman P; Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Konijnenberg MW; Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Ezziddin S; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany.
Nagarajah J; Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Heskamp S; Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 May; Vol. 49 (6), pp. 2064-2076. Date of Electronic Publication: 2021 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Lutetium*
Positron Emission Tomography Computed Tomography*/methods
Animals ; Cell Line, Tumor ; Dipeptides ; Heterocyclic Compounds, 1-Ring ; Humans ; Ligands ; Mice ; Mice, Nude ; Positron-Emission Tomography/methods ; Prostate-Specific Antigen ; Radioisotopes ; Radiopharmaceuticals/pharmacokinetics ; Tissue Distribution
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An Explorative Study of the Incidental High Renal Excretion of [ F]PSMA-1007 for Prostate Cancer PET/CT Imaging.
Autorzy:
Allach Y; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.; Department of Cardiology, Erasmus MC, 3015 CE Rotterdam, The Netherlands.
Banda A; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
van Gemert W; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
de Groot M; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
Derks Y; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
Schilham M; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
Hoepping A; Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds GmbH, 1454 Radeberg, Germany.
Perk L; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
Gotthardt M; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
Janssen M; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
Nagarajah J; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
Privé BM; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Apr 21; Vol. 14 (9). Date of Electronic Publication: 2022 Apr 21.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
[ Lu]Lu-PSMA-617 treatment.
Autorzy:
Peters SMB; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. .
Hofferber R; Department of Nuclear Medicine, Essen University Hospital, Essen, Germany.
Privé BM; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
de Bakker M; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Gotthardt M; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Janssen M; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
de Lange F; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Muselaers CHJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Costa PF; Department of Nuclear Medicine, Essen University Hospital, Essen, Germany.
Nagarajah J; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Konijnenberg MW; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.
Jentzen W; Department of Nuclear Medicine, Essen University Hospital, Essen, Germany.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Mar; Vol. 49 (4), pp. 1101-1112. Date of Electronic Publication: 2021 Oct 08.
Typ publikacji:
Journal Article
MeSH Terms:
Gallium Radioisotopes*
Prostatic Neoplasms, Castration-Resistant*/pathology
Dipeptides ; Heterocyclic Compounds, 1-Ring ; Humans ; Lutetium ; Male ; Organs at Risk/pathology ; Positron Emission Tomography Computed Tomography/methods ; Positron-Emission Tomography ; Prostate-Specific Antigen ; Radiopharmaceuticals/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Intra-therapeutic dosimetry of [ Lu]Lu-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer patients and correlation with treatment outcome.
Autorzy:
Peters SMB; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. .
Privé BM; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
de Bakker M; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
de Lange F; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Jentzen W; Department of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany.
Eek A; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Muselaers CHJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Gotthardt M; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Nagarajah J; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Konijnenberg MW; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Jan; Vol. 49 (2), pp. 460-469. Date of Electronic Publication: 2021 Jul 04.
Typ publikacji:
Journal Article
MeSH Terms:
Lutetium*/adverse effects
Lutetium*/pharmacokinetics
Lutetium*/therapeutic use
Prostate-Specific Antigen*/adverse effects
Prostate-Specific Antigen*/blood
Prostate-Specific Antigen*/pharmacokinetics
Prostate-Specific Antigen*/therapeutic use
Prostatic Neoplasms*/blood
Prostatic Neoplasms*/metabolism
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/secondary
Radiopharmaceuticals*/adverse effects
Radiopharmaceuticals*/pharmacokinetics
Radiopharmaceuticals*/therapeutic use
Hormones/metabolism ; Humans ; Male ; Organs at Risk/diagnostic imaging ; Organs at Risk/radiation effects ; Prospective Studies ; Radiation Dosage ; Single Photon Emission Computed Tomography Computed Tomography ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports.
Autorzy:
Uijen MJM; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Derks YHW; Department of Medical Imaging, Nuclear Medicine, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Merkx RIJ; Department of Medical Imaging, Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Schilham MGM; Department of Medical Imaging, Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Roosen J; Department of Medical Imaging, Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Privé BM; Department of Medical Imaging, Nuclear Medicine, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
van Lith SAM; Department of Medical Imaging, Nuclear Medicine, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
van Herpen CML; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Gotthardt M; Department of Medical Imaging, Nuclear Medicine, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Heskamp S; Department of Medical Imaging, Nuclear Medicine, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
van Gemert WAM; Department of Medical Imaging, Nuclear Medicine, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Nagarajah J; Department of Medical Imaging, Nuclear Medicine, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. james.nagarajah@radboudumc.nl.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Dec; Vol. 48 (13), pp. 4350-4368. Date of Electronic Publication: 2021 Jun 12.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms, Castration-Resistant*
Dipeptides ; Heterocyclic Compounds, 1-Ring ; Humans ; Male ; Positron Emission Tomography Computed Tomography ; Radioisotopes
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial.
Autorzy:
Privé BM; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
Janssen MJR; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
van Oort IM; Department of Urology, Radboudumc, Nijmegen, The Netherlands.
Muselaers CHJ; Department of Urology, Radboudumc, Nijmegen, The Netherlands.
Jonker MA; Department of Health Evidence, Radboudumc, Nijmegen, The Netherlands.
van Gemert WA; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
de Groot M; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
Westdorp H; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.
Mehra N; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.
Verzijlbergen JF; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
Scheenen TWJ; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
Zámecnik P; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
Barentsz JO; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
Gotthardt M; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
Noordzij W; Department of Radiology and Nuclear Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Vogel WV; Department of Radiology and Nuclear Medicine, NKI Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Radiation Oncology, NKI Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Bergman AM; Department of Medical Oncology, NKI Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
van der Poel HG; Department of Urology, NKI Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Vis AN; Department of Urology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Gerritsen WR; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.
Witjes JA; Department of Urology, Radboudumc, Nijmegen, The Netherlands.
Nagarajah J; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands. james.nagarajah@radboudumc.nl.
Pokaż więcej
Źródło:
Trials [Trials] 2021 Nov 04; Vol. 22 (1), pp. 768. Date of Electronic Publication: 2021 Nov 04.
Typ publikacji:
Letter; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Androgen Antagonists*
Prostatic Neoplasms, Castration-Resistant*/diagnostic imaging
Prostatic Neoplasms, Castration-Resistant*/drug therapy
Hormones ; Humans ; Lutetium/adverse effects ; Male ; Radioisotopes
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Outcome of Lu-PSMA-617 Radioligand Therapy in Chemo-Refractory Patients with Metastatic Castration-Resistant Early-Onset Prostate Cancer.
Autorzy:
Mader N; Department of Nuclear Medicine, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.
Groener D; Department of Nuclear Medicine, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.
Tselis N; Department of Radiation Oncology, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.
Banek S; Department of Urology, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.
Nagarajah J; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Grünwald F; Department of Nuclear Medicine, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.
Sabet A; Department of Nuclear Medicine, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Aug 20; Vol. 13 (16). Date of Electronic Publication: 2021 Aug 20.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Digoxin treatment reactivates in vivo radioactive iodide uptake and correlates with favorable clinical outcome in non-medullary thyroid cancer.
Autorzy:
Crezee T; Department of Pathology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Geert Grooteplein Zuid 10, Nijmegen, 6500 HB, The Netherlands. .
Tesselaar MH; Department of Pathology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Geert Grooteplein Zuid 10, Nijmegen, 6500 HB, The Netherlands.
Nagarajah J; Department of Radiology & Nuclear Medicine, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Corver WE; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Morreau J; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Pritchard C; Department of Pathology, University of Leicester, Leicester, LEI7RH, UK.
Kimura S; Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Kuiper JG; PHARMO Institute, Utrecht, The Netherlands.
van Engen-van Grunsven I; Department of Pathology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Geert Grooteplein Zuid 10, Nijmegen, 6500 HB, The Netherlands.
Smit JWA; Department of Internal Medicine, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Netea-Maier RT; Department of Internal Medicine, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Plantinga TS; Department of Pathology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Geert Grooteplein Zuid 10, Nijmegen, 6500 HB, The Netherlands.
Pokaż więcej
Źródło:
Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2021 Jun; Vol. 44 (3), pp. 611-625. Date of Electronic Publication: 2021 Feb 03.
Typ publikacji:
Journal Article
MeSH Terms:
Digoxin/*therapeutic use
Iodine Radioisotopes/*therapeutic use
Radiation Tolerance/*drug effects
Thyroid Cancer, Papillary/*therapy
Thyroid Neoplasms/*therapy
Aged ; Aged, 80 and over ; Animals ; Autophagy/drug effects ; Cell Proliferation/drug effects ; Female ; Humans ; Male ; Mice ; Radiation-Sensitizing Agents/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Optimal F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer.
Autorzy:
Draulans C; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium. .; Department of Oncology, KU Leuven, Leuven, Belgium. .
De Roover R; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium.
van der Heide UA; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Kerkmeijer L; Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Department of Radiation Oncology, University Medical Centre, Utrecht, The Netherlands.
Smeenk RJ; Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Pos F; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Vogel WV; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Nagarajah J; Department of Radiology & Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.
Janssen M; Department of Radiology & Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.
Isebaert S; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium.
Maes F; Department of Electrical Engineering, ESAT/PSI, KU Leuven, Leuven, Belgium.; Medical Imaging Research Centre, University Hospitals Leuven, Leuven, Belgium.
Mai C; Department of Radiology, University Hospitals Leuven, Leuven, Belgium.
Oyen R; Department of Radiology, University Hospitals Leuven, Leuven, Belgium.
Joniau S; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Kunze-Busch M; Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Goffin K; Department of Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium.
Haustermans K; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium. .; Department of Oncology, KU Leuven, Leuven, Belgium. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Apr; Vol. 48 (4), pp. 1211-1218. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Positron Emission Tomography Computed Tomography*
Prostatic Neoplasms*/diagnostic imaging
Edetic Acid/analogs & derivatives ; Gallium Isotopes ; Gallium Radioisotopes ; Humans ; Male ; Oligopeptides ; Tumor Burden
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prior PSMA PET-CT Imaging and Hounsfield Unit Impact on Tumor Yield and Success of Molecular Analyses from Bone Biopsies in Metastatic Prostate Cancer.
Autorzy:
Smits M; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Ekici K; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Pamidimarri Naga S; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
van Oort IM; Department of Urology, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Sedelaar MJP; Department of Urology, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Schalken JA; Department of Urology, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Nagarajah J; Department of Radiology and Nuclear Medicine, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.; Department of Nuclear Medicine, Technical University, Arcisstraße 21, 80333 Munich, Germany.
Scheenen TWJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Fütterer JJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Mehra N; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 Dec 14; Vol. 12 (12). Date of Electronic Publication: 2020 Dec 14.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial.
Autorzy:
Privé BM; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
Janssen MJR; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
van Oort IM; Department of Urology, Radboudumc, Nijmegen, The Netherlands.
Muselaers CHJ; Department of Urology, Radboudumc, Nijmegen, The Netherlands.
Jonker MA; Department of Health Evidence, Radboudumc, Nijmegen, The Netherlands.
de Groot M; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
Mehra N; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.
Verzijlbergen JF; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
Scheenen TWJ; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
Zámecnik P; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
Barentsz JO; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
Gotthardt M; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
Noordzij W; Department of Radiology and Nuclear Medicine, University Medical Center Groningen, Groningen, The Netherlands.
Vogel WV; Department of Radiology and Nuclear Medicine, NKI Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Radiation Oncology, NKI Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Bergman AM; Department of Medical Oncology, NKI Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
van der Poel HG; Department of Urology, NKI Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Vis AN; Department of Urology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Gerritsen WR; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.
Witjes JA; Department of Urology, Radboudumc, Nijmegen, The Netherlands.
Nagarajah J; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands. james.nagarajah@radboudumc.nl.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2020 Sep 14; Vol. 20 (1), pp. 884. Date of Electronic Publication: 2020 Sep 14.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Lutetium/*administration & dosage
Neoplasms, Hormone-Dependent/*drug therapy
Prostatic Neoplasms/*drug therapy
Prostatic Neoplasms, Castration-Resistant/*drug therapy
Radioisotopes/*administration & dosage
Androgen Antagonists/administration & dosage ; Androgen Antagonists/adverse effects ; Disease Progression ; Hormones/genetics ; Hormones/metabolism ; Humans ; Lutetium/adverse effects ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasms, Hormone-Dependent/pathology ; Neoplasms, Hormone-Dependent/radiotherapy ; Progression-Free Survival ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/radiotherapy ; Prostatic Neoplasms, Castration-Resistant/pathology ; Prostatic Neoplasms, Castration-Resistant/radiotherapy ; Quality of Life ; Radioisotopes/adverse effects ; Radiopharmaceuticals/administration & dosage ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Quantitative performance of I PET/CT as reference.
Autorzy:
Jentzen W; Department of Nuclear Medicine, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
Phaosricharoen J; Department of Nuclear Medicine, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
Gomez B; Department of Nuclear Medicine, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
Hetkamp P; Department of Nuclear Medicine, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
Stebner V; Department of Nuclear Medicine, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
Binse I; Department of Nuclear Medicine, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
Kinner S; Department of Radiology, University of Duisburg-Essen, Essen, Germany.
Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
Sabet A; Department of Nuclear Medicine, University Hospital Frankfurt, Frankfurt, Germany.
Nagarajah J; Department of Nuclear Medicine, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany. james.nagarajah@uk-essen.de.; Radboudumc, Department of Radiology and Nuclear Medicine, Nijmegen, The Netherlands. james.nagarajah@uk-essen.de.
Pokaż więcej
Źródło:
EJNMMI physics [EJNMMI Phys] 2018 Jul 19; Vol. 5 (1), pp. 13. Date of Electronic Publication: 2018 Jul 19.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 27

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies